000			02065 a2200541 4500
005			20250515043231.0
264		0	_c20070405
008			200704s 0 0 eng d
022			_a0923-7534
024	7		_a10.1093/annonc/mdl340 _2doi
040			_aNLM _beng _cNLM
100	1		_aWagner, A D
245	0	0	_aGemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO). _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cJan 2007
300			_a82-87 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650	0	4	_aAdenocarcinoma _xdrug therapy
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDisease Progression
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOrganoplatinum Compounds _xadministration & dosage
650	0	4	_aOxaliplatin
650	0	4	_aPancreatic Neoplasms _xdrug therapy
650	0	4	_aQuality of Life
650	0	4	_aSurvival Rate
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aGemcitabine
700	1		_aBuechner-Steudel, P
700	1		_aWein, A
700	1		_aSchmalenberg, H
700	1		_aLindig, U
700	1		_aMoehler, M
700	1		_aBehrens, R
700	1		_aKleber, G
700	1		_aKuss, O
700	1		_aFleig, W E
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 18 _gno. 1 _gp. 82-87
856	4	0	_uhttps://doi.org/10.1093/annonc/mdl340 _zAvailable from publisher's website
999			_c16607160 _d16607160